Scinai Immunotherapeutics Ltd. (SCNI)
0.483
-0.02
(-3.40%)
USD |
NASDAQ |
Jun 02, 16:00
0.483
0.00 (0.00%)
After-Hours: 18:27
Scinai Immunotherapeutics Profit Margin (Quarterly) : -787.5% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Compugen Ltd. | -352.4% |
| Pluri, Inc. | -3.70K% |
| Evogene Ltd. | -1.77K% |
| CollPlant Biotechnologies Ltd. | -4.24K% |
| Regentis Biomaterials Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -96.89% |
| Return on Assets | -68.08% |
| Return on Invested Capital | -76.98% |
| Operating Margin (Quarterly) | -343.6% |
| Return on Net Operating Assets | -80.01% |